Shopping Cart 0
Cart Subtotal
AED 0

Cumberland Pharmaceuticals Inc (CPIX) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Cumberland Pharmaceuticals Inc (CPIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cumberland Pharmaceuticals Inc (Cumberland Pharma) is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products. Its primary target markets are hospital acute care, gastroenterology and cancer supportive care. The company offers branded prescription products under Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Ethyol, Totect, Hepatoren, Boxaban, Vasculan, Portaban and RediTrex brand names. Cumberland Pharma promotes approved products through its hospital and gastroenterology sales forces in the US. It is also establishing a network of international partners to bring its products to patients in their countries. Cumberland Pharma is headquartered in Nashville, Tennessee, the US.

Cumberland Pharmaceuticals Inc Key Recent Developments

May 14,2019: Cumberland Pharmaceuticals reports 38% revenue growth in the first quarter

Feb 26,2019: Cumberland Pharmaceuticals announces fourth quarter revenue growth of 16%

Nov 13,2018: Cumberland Pharmaceuticals reports third quarter 2018 financial results

Sep 24,2018: Cumberland Pharmaceuticals announces Senior Music Industry Executive joins its Board Of Directors

Aug 14,2018: Cumberland Pharmaceuticals reports second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Cumberland Pharmaceuticals Inc - Key Facts

Cumberland Pharmaceuticals Inc - Key Employees

Cumberland Pharmaceuticals Inc - Key Employee Biographies

Cumberland Pharmaceuticals Inc - Major Products and Services

Cumberland Pharmaceuticals Inc - History

Cumberland Pharmaceuticals Inc - Company Statement

Cumberland Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview

Cumberland Pharmaceuticals Inc - Business Description

Product Category: Acetadote

Performance

Product Category: Acetadote (acetylcysteine)

Overview

Product Category: Caldolor

Overview

Performance

Product Category: Ethyol

Overview

Performance

Product Category: Kristalose

Overview

Product Category: Kristalose (lactulose)

Performance

Product Category: Omeclamox

Overview

Performance

Product Category: Other

Performance

Product Category: Totect

Overview

Performance

Product Category: Vaprisol

Overview

Performance

Product Category: Vibativ

Overview

Performance

R&D Overview

Cumberland Pharmaceuticals Inc - Corporate Strategy

Cumberland Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Cumberland Pharmaceuticals Inc - Strengths

Cumberland Pharmaceuticals Inc - Weaknesses

Cumberland Pharmaceuticals Inc - Opportunities

Cumberland Pharmaceuticals Inc - Threats

Cumberland Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Company's Lifesciences Financial Deals and Alliances

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cumberland Pharmaceuticals Inc, Recent Deals Summary

Section 5 - Company's Recent Developments

May 14, 2019: Cumberland Pharmaceuticals reports 38% revenue growth in the first quarter

Feb 26, 2019: Cumberland Pharmaceuticals announces fourth quarter revenue growth of 16%

Nov 13, 2018: Cumberland Pharmaceuticals reports third quarter 2018 financial results

Sep 24, 2018: Cumberland Pharmaceuticals announces Senior Music Industry Executive joins its Board Of Directors

Aug 14, 2018: Cumberland Pharmaceuticals reports second quarter 2018 financial results

Aug 07, 2018: Cumberland Pharmaceuticals appoints new senior executive

Jul 24, 2018: Cumberland Emerging Technologies announces board appointments

Jun 05, 2018: LSU Health New Orleans and Cumberland Emerging Technologies Announce Collaboration Agreement

May 08, 2018: Cumberland Pharmaceuticals Reports First Quarter 2018 Financial Results

May 07, 2018: Cumberland Pharmaceuticals Appoints New Senior Executive

Section 6 - Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Cumberland Pharmaceuticals Inc, Performance Chart (2014 - 2018)

Cumberland Pharmaceuticals Inc, Ratio Charts

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Cumberland Pharmaceuticals Inc, Key Facts

Cumberland Pharmaceuticals Inc, Key Employees

Cumberland Pharmaceuticals Inc, Key Employee Biographies

Cumberland Pharmaceuticals Inc, Major Products and Services

Cumberland Pharmaceuticals Inc, History

Cumberland Pharmaceuticals Inc, Subsidiaries

Cumberland Pharmaceuticals Inc, Key Competitors

Cumberland Pharmaceuticals Inc, Ratios based on current share price

Cumberland Pharmaceuticals Inc, Annual Ratios

Cumberland Pharmaceuticals Inc, Annual Ratios (Cont...1)

Cumberland Pharmaceuticals Inc, Annual Ratios (Cont...2)

Cumberland Pharmaceuticals Inc, Interim Ratios

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cumberland Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Cumberland Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Pfizer Inc

Perrigo Co Plc

Ironwood Pharmaceuticals Inc

Takeda Pharmaceutical Co Ltd

Sucampo Pharmaceuticals Inc

Sagent Pharmaceuticals Inc

ContraFect Corp

Cumberland Pharmaceuticals Inc (CPIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description - A detailed description of the company's operations and business divisions.

- Corporate strategy - Analyst's summarization of the company's business strategy.

- SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history - Progression of key events associated with the company.

- Major products and services - A list of major products, services and brands of the company.

- Key competitors - A list of key competitors to the company.

- Key employees - A list of the key executives of the company.

- Executive biographies - A brief summary of the executives' employment history.

- Key operational heads - A list of personnel heading key departments/functions.

- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities - A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cumberland Pharmaceuticals Inc (Cumberland Pharma) is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products. Its primary target markets are hospital acute care, gastroenterology and cancer supportive care. The company offers branded prescription products under Acetadote, Caldolor, Kristalose, Omeclamox, Vaprisol, Ethyol, Totect, Hepatoren, Boxaban, Vasculan, Portaban and RediTrex brand names. Cumberland Pharma promotes approved products through its hospital and gastroenterology sales forces in the US. It is also establishing a network of international partners to bring its products to patients in their countries. Cumberland Pharma is headquartered in Nashville, Tennessee, the US.

Cumberland Pharmaceuticals Inc Key Recent Developments

May 14,2019: Cumberland Pharmaceuticals reports 38% revenue growth in the first quarter

Feb 26,2019: Cumberland Pharmaceuticals announces fourth quarter revenue growth of 16%

Nov 13,2018: Cumberland Pharmaceuticals reports third quarter 2018 financial results

Sep 24,2018: Cumberland Pharmaceuticals announces Senior Music Industry Executive joins its Board Of Directors

Aug 14,2018: Cumberland Pharmaceuticals reports second quarter 2018 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Cumberland Pharmaceuticals Inc - Key Facts

Cumberland Pharmaceuticals Inc - Key Employees

Cumberland Pharmaceuticals Inc - Key Employee Biographies

Cumberland Pharmaceuticals Inc - Major Products and Services

Cumberland Pharmaceuticals Inc - History

Cumberland Pharmaceuticals Inc - Company Statement

Cumberland Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 - Company Analysis

Company Overview

Cumberland Pharmaceuticals Inc - Business Description

Product Category: Acetadote

Performance

Product Category: Acetadote (acetylcysteine)

Overview

Product Category: Caldolor

Overview

Performance

Product Category: Ethyol

Overview

Performance

Product Category: Kristalose

Overview

Product Category: Kristalose (lactulose)

Performance

Product Category: Omeclamox

Overview

Performance

Product Category: Other

Performance

Product Category: Totect

Overview

Performance

Product Category: Vaprisol

Overview

Performance

Product Category: Vibativ

Overview

Performance

R&D Overview

Cumberland Pharmaceuticals Inc - Corporate Strategy

Cumberland Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Cumberland Pharmaceuticals Inc - Strengths

Cumberland Pharmaceuticals Inc - Weaknesses

Cumberland Pharmaceuticals Inc - Opportunities

Cumberland Pharmaceuticals Inc - Threats

Cumberland Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 - Company's Lifesciences Financial Deals and Alliances

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cumberland Pharmaceuticals Inc, Recent Deals Summary

Section 5 - Company's Recent Developments

May 14, 2019: Cumberland Pharmaceuticals reports 38% revenue growth in the first quarter

Feb 26, 2019: Cumberland Pharmaceuticals announces fourth quarter revenue growth of 16%

Nov 13, 2018: Cumberland Pharmaceuticals reports third quarter 2018 financial results

Sep 24, 2018: Cumberland Pharmaceuticals announces Senior Music Industry Executive joins its Board Of Directors

Aug 14, 2018: Cumberland Pharmaceuticals reports second quarter 2018 financial results

Aug 07, 2018: Cumberland Pharmaceuticals appoints new senior executive

Jul 24, 2018: Cumberland Emerging Technologies announces board appointments

Jun 05, 2018: LSU Health New Orleans and Cumberland Emerging Technologies Announce Collaboration Agreement

May 08, 2018: Cumberland Pharmaceuticals Reports First Quarter 2018 Financial Results

May 07, 2018: Cumberland Pharmaceuticals Appoints New Senior Executive

Section 6 - Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Cumberland Pharmaceuticals Inc, Performance Chart (2014 - 2018)

Cumberland Pharmaceuticals Inc, Ratio Charts

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Cumberland Pharmaceuticals Inc, Key Facts

Cumberland Pharmaceuticals Inc, Key Employees

Cumberland Pharmaceuticals Inc, Key Employee Biographies

Cumberland Pharmaceuticals Inc, Major Products and Services

Cumberland Pharmaceuticals Inc, History

Cumberland Pharmaceuticals Inc, Subsidiaries

Cumberland Pharmaceuticals Inc, Key Competitors

Cumberland Pharmaceuticals Inc, Ratios based on current share price

Cumberland Pharmaceuticals Inc, Annual Ratios

Cumberland Pharmaceuticals Inc, Annual Ratios (Cont...1)

Cumberland Pharmaceuticals Inc, Annual Ratios (Cont...2)

Cumberland Pharmaceuticals Inc, Interim Ratios

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Cumberland Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Cumberland Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Cumberland Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Pfizer Inc

Perrigo Co Plc

Ironwood Pharmaceuticals Inc

Takeda Pharmaceutical Co Ltd

Sucampo Pharmaceuticals Inc

Sagent Pharmaceuticals Inc

ContraFect Corp

chat_bubbleLet's Chat